#rapidresults — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #rapidresults, aggregated by home.social.
-
DATE: September 14, 2026 at 07:00AM
SOURCE: STAT NEWS MENTAL HEALTHTITLE: STAT+: Definium’s LSD therapy eased anxiety in second large trial
Definium Therapeutics said Monday that its LSD therapy helped patients with anxiety in a second late-stage trial, setting up the company to seek the first approval of a psychedelic drug for anxiety.
In the 12-week trial, patients taking a 100-microgram dose of the drug, called DT120, experienced a 9.8-point drop on a test called the Hamilton Anxiety Rating Scale, while those on placebo experienced a 4.7-point drop. The difference of 5.1 points is similar to what was seen in Definium’s first late-stage anxiety study and larger than what’s been observed with many other anxiety therapies, though it’s difficult to compare results across studies.
Definium is among the first wave of biotechs nearing regulatory approval for psychedelic therapies, a class of treatments that may be especially attractive to patients since they appear to exert rapid benefits. (In the latest trial, Definium said patients experienced changes as early as the second day after dosing.) In contrast, the effects of traditional options like antidepressants take weeks to kick in.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/topic/mental-health/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DefiniumTherapeutics #DT120 #LSDtherapy #anxietytreatment #psychedelicmedicine #lateStageTrial #HamiltonAnxietyRatingScale #rapidresults #psychedelicdrugs #biotechnews
-
DATE: September 14, 2026 at 07:00AM
SOURCE: STAT NEWS MENTAL HEALTHTITLE: STAT+: Definium’s LSD therapy eased anxiety in second large trial
Definium Therapeutics said Monday that its LSD therapy helped patients with anxiety in a second late-stage trial, setting up the company to seek the first approval of a psychedelic drug for anxiety.
In the 12-week trial, patients taking a 100-microgram dose of the drug, called DT120, experienced a 9.8-point drop on a test called the Hamilton Anxiety Rating Scale, while those on placebo experienced a 4.7-point drop. The difference of 5.1 points is similar to what was seen in Definium’s first late-stage anxiety study and larger than what’s been observed with many other anxiety therapies, though it’s difficult to compare results across studies.
Definium is among the first wave of biotechs nearing regulatory approval for psychedelic therapies, a class of treatments that may be especially attractive to patients since they appear to exert rapid benefits. (In the latest trial, Definium said patients experienced changes as early as the second day after dosing.) In contrast, the effects of traditional options like antidepressants take weeks to kick in.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/topic/mental-health/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DefiniumTherapeutics #DT120 #LSDtherapy #anxietytreatment #psychedelicmedicine #lateStageTrial #HamiltonAnxietyRatingScale #rapidresults #psychedelicdrugs #biotechnews
-
DATE: September 14, 2026 at 07:00AM
SOURCE: STAT NEWS MENTAL HEALTHTITLE: STAT+: Definium’s LSD therapy eased anxiety in second large trial
Definium Therapeutics said Monday that its LSD therapy helped patients with anxiety in a second late-stage trial, setting up the company to seek the first approval of a psychedelic drug for anxiety.
In the 12-week trial, patients taking a 100-microgram dose of the drug, called DT120, experienced a 9.8-point drop on a test called the Hamilton Anxiety Rating Scale, while those on placebo experienced a 4.7-point drop. The difference of 5.1 points is similar to what was seen in Definium’s first late-stage anxiety study and larger than what’s been observed with many other anxiety therapies, though it’s difficult to compare results across studies.
Definium is among the first wave of biotechs nearing regulatory approval for psychedelic therapies, a class of treatments that may be especially attractive to patients since they appear to exert rapid benefits. (In the latest trial, Definium said patients experienced changes as early as the second day after dosing.) In contrast, the effects of traditional options like antidepressants take weeks to kick in.
Continue to STAT+ to read the full story…
-------------------------------------------------
STAT News reports "from the frontiers of health and medicine".
Learn more at https://www.statnews.com/topic/mental-health/ .
See also their complete Mastodon account at @STAT .
This robot is NOT affiliated with STAT news and merely rebroadcasts from their site. Responses posted here are not monitored.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DefiniumTherapeutics #DT120 #LSDtherapy #anxietytreatment #psychedelicmedicine #lateStageTrial #HamiltonAnxietyRatingScale #rapidresults #psychedelicdrugs #biotechnews